Additive nephrotoxicity from roentgenographic contrast media. Its occurrence in phenazopyridine-induced acute renal failure.
A 68-year-old woman had reversible nonoliguric acute renal failure and yellow pigmentation of her skin and sclerae after ingesting phenazopyridine hydrochloride, 200 mg four times a day for six weeks. Although she began to recover renal function promptly after the drug therapy was discontinued, there was a further decline in her glomerular filtration rate after an oral cholecystogram and intravenous pyelogram. Phenazopyridine-induced acute renal failure is rare, but its early recognition is important so that additional nephrotoxicity from studies using roentgenographic contrast material may be avoided in patients with this problem.
D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000000981:diagnostic imaging; D000368:Aged; D000631:Aminopyridines / Q000009:adverse effects*; D003973:Diatrizoate / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007480:Iopanoic Acid / Q000009:adverse effects*; D007668:Kidney / Q000187:drug effects; D010621:Phenazopyridine / Q000008:administration & dosage / Q000009:adverse effects*; D011859:Radiography; D012880:Skin Pigmentation
D000631:Aminopyridines; D003973:Diatrizoate; D007480:Iopanoic Acid; D010621:Phenazopyridine